CDB Brands Appoints Douglas McKinnon as CFO
Separator

CDB Brands Appoints Douglas McKinnon as CFO

Separator
CDB Brands Appoints Douglas McKinnon as CFO

CEO Insights Team

CBD Brands, a cutting-edge wellness company developing a proprietary line of products designed to explore the multiple therapeutic and medical uses of cannabidiol (CBD), announced its appointment of Douglas McKinnon as CFO. With more than 35 years’ global corporate finance experience advising companies in Mergers & Acquisitions, Initial Public Offerings, and capital raises, Douglas brings a wealth of deal experience to the CBD Brands management team.

Before joining the company, Douglas served in multiple C-level executive positions in both the private and public sectors, including Chairman, CEO, and CFO. While VP–Chief Administrative Officer of a $12 billion market cap NASDAQ-traded company the management team raised over $2 billion. During his career, Douglas has served as CFO of several publicly held US, Canadian and Australian companies, and CEO/CFO of various private companies.

“Doug joins us at an important time in the development of our company. His extensive corporate finance

His extensive corporate finance experience will be invaluable as we seek to grow CBD Brands both organically as well as through mergers and acquisitions



experience will be invaluable as we seek to grow CBD Brands both organically as well as through mergers and acquisitions,” says Brian John, CEO, CBD Brands. “With his track record of growing companies and building shareholder value, we are thrilled to welcome Doug to our team. The CFO role is critical to executing our strategic initiatives as well as the overall financial success of our company,” he adds.

Douglas’ experience includes start-up companies utilizing venture capital to billion-dollar public companies. Additionally, he has extensive M&A and turnaround experience. Douglas received a BBA and an MBA from Texas Christian University He worked for nine years as a CPA in the SEC and the oil and gas practice section and member of the O&G Technical Committee of Coopers & Lybrand (PWC).

CBD Brands is dedicated to advancing research into the medical and therapeutic uses of CBD for treatment and relief of ultraviolet exposure, psoriasis, eczema, skin aging, and other ailments. The company was formed in 2018 and is headquartered in Jupiter, Florida.